Clinical Trial Update: Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age [Phase 4]

View source ↗

Summary

Clinical trial update for switching to B/F/TAF in treatment-experienced people with HIV aged 65 and older (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• B/F/TAF (emtricitabine/tenofovir alafenamide/cobicistat-darunavir)

Snippet

Sponsor: Tulika Singh, MD | Conditions: HIV-1-infection | Phase 4 | Status: UNKNOWN